Search for: "Jacqueline Berman"
Results 21 - 40
of 63
Sorted by Relevance
|
Sort by Date
26 Oct 2023, 10:00 pm
Partners Jacqueline Berman and Maarika Kimbrell wrote an article for Law360 summarizing draft guidance from the US Food and Drug Administration that revises its approach to the dissemination of scientific information on unapproved uses (SIUU) of approved or cleared medical products. [read post]
1 Feb 2023, 10:00 pm
Partner Jacqueline Berman and associate Nikita Bhojani wrote a Law360 Expert Analysis article on how a new US Food and Drug Administration notice—which contrasts with an Eleventh Circuit ruling on orphan drug exclusivity—makes the scope of orphan drug exclusivity periods appear uncertain. [read post]
26 Oct 2023, 10:00 pm
Partners Jacqueline Berman and Maarika Kimbrell wrote an article for Law360 summarizing draft guidance from the US Food and Drug Administration that revises its approach to the dissemination of scientific information on unapproved uses (SIUU) of approved or cleared medical products. [read post]
17 Apr 2023, 10:00 pm
In an article for Clinical Leader , partner Jacqueline Berman and associate Angela Silva report that while many provisions of the US Congress’ FY 2023 Consolidated Appropriations Act (Omnibus) have received attention, one provision has flown under the radar. [read post]
17 Apr 2023, 10:00 pm
In an article for Clinical Leader , partner Jacqueline Berman and associate Angela Silva report that while many provisions of the US Congress’ FY 2023 Consolidated Appropriations Act (Omnibus) have received attention, one provision has flown under the radar. [read post]
18 Jan 2024, 10:00 pm
To help define a path forward, Morgan Lewis FDA and healthcare partners Jacqueline Berman, Rebecca Dandeker, Maarika Kimbrell, and Kathleen Sanzo have assembled an in-depth report on drug and biologic developments at the FDA. [read post]
18 Jan 2024, 10:00 pm
To help define a path forward, Morgan Lewis FDA and healthcare partners Jacqueline Berman, Rebecca Dandeker, Maarika Kimbrell, and Kathleen Sanzo have assembled an in-depth report on drug and biologic developments at the FDA. [read post]
18 Jan 2024, 10:00 pm
To help define a path forward, Morgan Lewis FDA and healthcare partners Jacqueline Berman, Rebecca Dandeker, Maarika Kimbrell, and Kathleen Sanzo have assembled an in-depth report on drug and biologic developments at the FDA. [read post]
17 Apr 2023, 10:00 pm
Partners Kathleen Sanzo, Jacqueline Berman, and David Salmons wrote a Law360 Expert Analysis article. [read post]
18 Jan 2024, 10:00 pm
To help define a path forward, Morgan Lewis FDA and healthcare partners Jacqueline Berman, Rebecca Dandeker, Maarika Kimbrell, and Kathleen Sanzo have assembled an in-depth report on drug and biologic developments at the FDA. [read post]
18 Sep 2022, 10:00 pm
Partners Jacqueline Berman and Kathleen Sanzo wrote an article for Law360 covering President Joseph Biden’s recent executive order on sustainability and innovation in biotechnology and biomanufacturing. [read post]
18 Jan 2024, 10:00 pm
To help define a path forward, Morgan Lewis FDA and healthcare partners Jacqueline Berman, Rebecca Dandeker, Maarika Kimbrell, and Kathleen Sanzo have assembled an in-depth report on drug and biologic developments at the FDA. [read post]
18 Sep 2022, 10:00 pm
Partners Jacqueline Berman and Kathleen Sanzo wrote an article for Law360 covering President Joseph Biden’s recent executive order on sustainability and innovation in biotechnology and biomanufacturing. [read post]
18 Sep 2022, 10:00 pm
Partners Jacqueline Berman and Kathleen Sanzo wrote an article for Law360 covering President Joseph Biden’s recent executive order on sustainability and innovation in biotechnology and biomanufacturing. [read post]
18 Sep 2022, 10:00 pm
Partners Jacqueline Berman and Kathleen Sanzo wrote an article for Law360 covering President Joseph Biden’s recent executive order on sustainability and innovation in biotechnology and biomanufacturing. [read post]
5 Apr 2020, 9:00 pm
Kathleen Sanzo, Jacqueline Berman, and Alexandre Gapihan itemize those conditions in their recently authored LawFlash. [read post]
17 Apr 2023, 10:00 pm
Partners Kathleen Sanzo, Jacqueline Berman, and David Salmons wrote a Law360 Expert Analysis article. [read post]
18 Jan 2024, 10:00 pm
To help define a path forward, Morgan Lewis FDA and healthcare partners Jacqueline Berman, Rebecca Dandeker, Maarika Kimbrell, and Kathleen Sanzo have assembled an in-depth report on drug and biologic developments at the FDA. [read post]
18 Sep 2022, 10:00 pm
Partners Jacqueline Berman and Kathleen Sanzo wrote an article for Law360 covering President Joseph Biden’s recent executive order on sustainability and innovation in biotechnology and biomanufacturing. [read post]
17 Apr 2023, 10:00 pm
Partners Kathleen Sanzo, Jacqueline Berman, and David Salmons wrote a Law360 Expert Analysis article. [read post]
